This site is intended for Healthcare Professionals only.

Search here...

Tag: Covid-19; emergency use authorisation; molnupiravir; remdesivir; dexamethasone

spot_imgspot_img

‘Price of Covid-19 treatments from Pfizer, Merck, GSK align with patient benefits’

Coronavirus Pri Mandav Pri Mandav -
The prices of drugs used to treat Covid-19 for those at risk of serious illness are "reasonably aligned" with how much they help patients,...

Merck seeks first US regulator’s authorisation for Covid-19 tablet

Coronavirus PB Staff Writer PB Staff Writer -
Pharmaceutical company Merck said today (October 11) it has applied for US emergency use authorisation for its tablet to treat mild-to-moderate patients of Covid-19, putting it on course to become the first oral...

Follow us

Engage with Experts: Connect with industry leaders, renowned pharmacists, and forward-thinking researchers through exclusive live Q&A sessions and engaging discussions. Tap into their wisdom, ask burning questions, and gain invaluable insights to fuel your passion for pharmacy

Company

Latest news

Creating smokefree generation: MPs to vote on Tobacco and Vapes Bill today

News 0
If passed, the bill will help deliver Prime Minister...

New registrations stopped: NHSE reviews mental health support for secondary care staff

News 0
The halt comes amidst shortage of staff, burnout and...

Pharmacy owner engagement event: Registration opens now

News 0
Community pharmacy owners are encouraged to share their views...

Popular news

EXCLUSIVE – Andrew Lane: Empowering pharmacy contactors

BIG INTERVIEW 0
After two days of intense deliberation on the future...

NHS to address workforce shortage by recruiting 2,000 doctors from India

News 0
The shortage of doctors in the country is attributed...

LloydsPharmacy confirms exit from the high street

News 0
The chain has closed four stores and sold all...

Copyright © 2023 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc

This site is intended for Healthcare Professionals only.